Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket

Gainers

Orchard Therapeutics plc (NASDAQ:ORTX) shares rose 95.5% to $15.80 in pre-market trading after the company inked a deal with Kyowa Kirin Co., Ltd. to be acquired for $16.00 per ADS in cash plus an additional contingent value right of $1.00 per ADS, representing a total value of about $477.6 million.
Meiwu Technology Company Limited (NASDAQ:WNW) shares gained 62.3% to $0.1573 in pre-market trading after falling 4% on Wednesday.
Molekule Group, Inc. (NASDAQ:MKUL) shares rose 38.7% to $0.1595 in pre-market trading. Molekule Group shares fell 44% on Wednesday after the company and its subsidiary filed for Chapter 11 bankruptcy.
Femasys Inc. (NASDAQ:FEMY) rose 27.5% to $2.92 in pre-market trading after falling 8% on Wednesday.
NKGen Biotech, Inc. (NASDAQ:NKGN) rose 20.9% to $5.96 in pre-market trading. NKGen Biotech recently announced that it has closed its previously announced business combination with Graf Acquisition Corp. IV.
Grom Social Enterprises, Inc. (NASDAQ:GROM) shares climbed 18.8% to $2.08 in pre-market trading after gaining around 13% on Wednesday.
Better Choice Company Inc. (NYSE:BTTR) shares jumped 15.5% to $0.1848 in pre-market trading after gaining 12% on Wednesday.
Momentus Inc. (NASDAQ:MNTS) gained 14.6% to $1.26 in pre-market trading. Momentus announced closing of $4.0 million registered direct offering priced at-the-market under Nasdaq rules.
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) shares rose 12.3% to $3.37 in pre-market trading. China SXT Pharmaceuticals reported a 1-for-25 reverse stock split.
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) shares surged 10.7% to $2.38 in pre-market trading after falling over 8% on Wednesday.

Losers

Now Read This: Dropbox, United States Steel And 2 Other Stocks Insiders Are Selling

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

Gainers

Orchard Therapeutics plc (NASDAQ:ORTX) shares rose 95.5% to $15.80 in pre-market trading after the company inked a deal with Kyowa Kirin Co., Ltd. to be acquired for $16.00 per ADS in cash plus an additional contingent value right of $1.00 per ADS, representing a total value of about $477.6 million.
Meiwu Technology Company Limited (NASDAQ:WNW) shares gained 62.3% to $0.1573 in pre-market trading after falling 4% on Wednesday.
Molekule Group, Inc. (NASDAQ:MKUL) shares rose 38.7% to $0.1595 in pre-market trading. Molekule Group shares fell 44% on Wednesday after the company and its subsidiary filed for Chapter 11 bankruptcy.
Femasys Inc. (NASDAQ:FEMY) rose 27.5% to $2.92 in pre-market trading after falling 8% on Wednesday.
NKGen Biotech, Inc. (NASDAQ:NKGN) rose 20.9% to $5.96 in pre-market trading. NKGen Biotech recently announced that it has closed its previously announced business combination with Graf Acquisition Corp. IV.
Grom Social Enterprises, Inc. (NASDAQ:GROM) shares climbed 18.8% to $2.08 in pre-market trading after gaining around 13% on Wednesday.
Better Choice Company Inc. (NYSE:BTTR) shares jumped 15.5% to $0.1848 in pre-market trading after gaining 12% on Wednesday.
Momentus Inc. (NASDAQ:MNTS) gained 14.6% to $1.26 in pre-market trading. Momentus announced closing of $4.0 million registered direct offering priced at-the-market under Nasdaq rules.
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) shares rose 12.3% to $3.37 in pre-market trading. China SXT Pharmaceuticals reported a 1-for-25 reverse stock split.
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) shares surged 10.7% to $2.38 in pre-market trading after falling over 8% on Wednesday.

Losers

Cambium Networks Corporation (NASDAQ:CMBM) fell 27.8% to $5.72 in pre-market trading after the company reported preliminary revenue for the third quarter. Cambium Networks said it sees revenues of $40 million to $45 million, versus prior forecast of $62 million to $70 million. The company also suspended its guidance for the full year 2023.
SIGNA Sports United N.V. (NYSE:SSU) fell 23.2% to $0.1090 in pre-market trading.
MaxCyte, Inc. (NASDAQ:MXCT) shares fell 21.4% to $2.57 in pre-market trading. MaxCyte said it sees third-quarter total revenue of $7.8 to 8.0 million, representing a decrease of 25% -27% versus the year-ago quarter. The company now expects total revenue of approximately $34 million to $36 million for the year.
Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) fell 13.8% to $3.45 in pre-market trading. Neoleukin Therapeutics recently reported a 1-for-5 reverse stock split.
Safety Shot, Inc. (NASDAQ:SHOT) fell 12% to $1.10 in pre-market trading after declining more than 10% on Wednesday.
Benson Hill, Inc. (NYSE:BHIL) shares fell 10.5% to $0.2913 in pre-market trading after gaining 3% on Wednesday.
Inspirato Incorporated (NASDAQ:ISPO) fell 10.3% to $0.56 in pre-market trading. Inspirato said it has closed its $25 million senior secured convertible note issued by Inspirato to Capital One Ventures.
Accolade Inc (NASDAQ:ACCD) shares fell 9.2% to $8.85 in pre-market trading after the company reported second-quarter results. Accolade said it sees FY24 revenue of $410 million to $414 million.
SeaStar Medical Holding Corporation (NASDAQ:SSU) fell 8.8% to $0.5392 in pre-market trading. SeaStar Medical recently issued a regulatory update regarding selective cytopheretic device use in pediatric acute kidney injury under a humanitarian device exemption.
Resources Connection, Inc. (NASDAQ:RGP) fell 8.5% to $13.25 in pre-market after the company reported first-quarter financial results.